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Males with obstructive sleep apnea syndrome (OSAS) may present decreased testosterone serum 
levels because of hypoxemia. 
Aim: To correlate testosterone levels in OSAS patients with laboratory parameters. 
Material and methods: 103 registries of OSAS patients were reviewed from 2002 to 2009. The 
following data collected: age when polysomnography was done, hematocrit and hemoglobin levels, 
total testosterone serum levels, BMI, apnea/hypopnea index (AHI), and O2 saturation. 
Study Design: A cross-sectional retrospective case study. 
Results: 79 patients (77%) had no hormonal changes, and 24 patients (23%) had decreased serum 
levels. In patients with normal testosterone levels, 70% were overweight; 63% with altered testosterone 
levels had obesity grade I (p<0.05). Patients with altered testosterone levels had significantly lower 
average doses of Ht, Hb and androgen compared to patients without altered androgen levels. The 
average BMI of patients with altered hormone levels was significantly higher compared to patients 
with normal hormone levels. 
Conclusions: The relationship between morning testosterone levels and obesity, and to a lesser 
degree age, AHI and hypoxemia may be the cause of central suppression of testosterone in these 
patients. Decreased blood HT and HB levels may be related to lower levels of circulating testosterone.
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INTRODUCTION
The obstructive sleep apnea/hypopnea syndrome 
(OSAHS) is a common respiratory condition that affects 
about 4% of males and 2% of females; it may be charac-
terized by recurring sleep-induced collapse of pharyngeal 
airways that result in hypoxemia and hypercapnia.1 Va-
riables that cause pharyngeal collapse include negative 
airway pressure during inspiration and positive pressure 
on the outside of these airways because of fat deposits 
and/or small jaws.2
Although the underlying mechanisms of sleep ap-
nea/hypopnea remain unknown, altered central nervous 
system control of upper airway muscles is an important 
component of this syndrome.3 The pathogenesis invol-
ves collapse of upper airways; for normal breathings, its 
patency depends on a specific dilator muscle. The genio-
glossus - one of the upper airway muscles - is the main 
extrinsic muscle for tongue protrusion; it is innervated by 
the hypoglossal nerve.2,4 The genioglossus contracts during 
inspiration, supporting lung ventilation and causing the 
upper airways to remain open. The central nervous system 
controls airway function from the nose to the bronchioles; 
it is an essential component of the breathing regulating 
system and airway patency during vigil and sleep. Seroto-
ninergic and noradrenergic neurons - in parallel pathways 
- may directly stimulate the motor cells of the hypoglossal 
nerve; they regulate the upper airway dilator muscles. A 
higher activity of these neurons increases the activity of 
the genioglossus muscle.4
Age and the level of sex hormones affect the sero-
toninergic function. Serotonin production in neurons of 
the anterior horn of the cervical spine (associated with the 
motor nucleus of the phrenic nerve) decreases with age.5 
There are several mechanisms by which estrogens elevate 
serotonin levels.6 Age-related changes in the serotoninergic 
system and their effect on respiratory motor control may 
occur indirectly by changes in gonadal hormone levels.7 
The effects of age and sex hormones on responses to hy-
poxia have not been investigated in depth, in particular 
their impact on respiratory plasticity following intermittent 
hypoxia.8,9 This is of significant interest, as several respira-
tory conditions, including the OSAHS, appear to be related 
to age and gender.10,11
Aromatase converts testosterone into estradiol, 
which mediates most of the actions of testosterone on the 
serotoninergic system; thus, testosterone in itself does not 
account for the degree of long-term facilitation - a form 
of respiratory plasticity expressed as a persistent elevation 
of phrenic and hypoglossal nerves following intermittent 
hypoxia. Sex hormone serum levels reflect circulating le-
vels - but not necessarily the level in respiration-associated 
areas of the central nervous system (caudal raphe and the 
phrenic and hypoglossal nerve nuclei). Aromatase is part 
of the group of p450 cytochrome enzymes; it is a mediator 
of aromatization, converting androgens into estrogens.7 
Serotoninergic neurons in the caudal raphe nuclei send 
projections to the motor nuclei of the hypoglossal and 
phrenic nerves; there is evidence that sex hormones mo-
dulate respiratory plasticity through the serotoninergic 
system.
Depletion of gonadal hormones may decrease sero-
tonin uptake in the hypoglossal and phrenic motor nuclei, 
thereby reducing long-term facilitation. Androgenic effects 
on the serotoninergic system appear to be indirect, reflec-
ting testosterone conversion into estradiol in the central 
nervous system.12 Lower estradiol levels reduce serotonin 
synthesis, release, reuse and degradation; terminal sero-
tonin levels and receptor density in several areas of the 
brain are also decreased. Thus, estradiol appears to have 
a key role in modulating serotoninergic function, thereby 
affecting long-term respiratory facilitation.13-15
OSAHS affects middle-aged men more often than 
women; thus, it is no surprise that testosterone is involved 
in respiratory control. Testosterone, estradiol and pro-
gesterone circulating levels decrease with age in men.16 
A few effects of sex hormones in respiratory control are 
mediated by aromatase-mediated testosterone conversion 
into estradiol in the brain.12 However, it is not clear if aro-
matase declines sufficiently to reduce respiratory plasticity 
as patients age.7 Reports of male subjects with OSAHS and 
low testosterone levels - regardless of age - have been 
published.17
The purpose of this study was to assess quantitative 
serum testosterone levels in patients with OSAHS, and to 
relate these levels with age, body-mass index, the apnea/
hypopnea index, maximum oxygen saturation, the hema-
tocrit (Ht), and hemoglobin (Hb).
SERIES AND METHOD
A retrospective cross-sectional study was made of 
103 registries of patients with a diagnosis of OSAHS from 
2002 to 2009. The inclusion criteria were as follows: a) 
subjects that met criteria A or B and the items in criteria 
C, for diagnosis.
A. excessive daytime drowsiness not explained by 
other causes.
B. two or more of the following, not explained by 
other causes:
gasping during sleep;
recurring awakenings during sleep;
restless sleep; 
daytime fatigue;
difficulty to concentrate.
C. nighttime monitoring showing more than five 
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episodes of respiratory obstruction per hour during sleep. 
These events may include any combination of obstruc-
tive apnea/hypopnea or respiratory effort related with 
awakening.
b) total testosterone dosage in the morning and a 
red blood count following polysomnography.
c) absence of other somatic or laboratory-identified 
disorders, as observed in the physical examination and 
work-up.
d) absence of craniofacial dimorphism or temporo-
mandibular disorders, as investigated in specific physical 
examinations.
e) absence of drug dependency, alcoholism, de-
pression, dementia, as investigated in a medical history 
and psychiatric assessment.
f) absence of apparent genetic syndromes, as inves-
tigated by a medical-genetic physical examination.
g) presence or not of other family cases.
h) maximum age - 70 years.
i) BMI ≤ 30.
j) male gender.
The following data were gathered: age when 
undergoing polysomnography, Ht and Hb values, total 
testosterone serum level, body-mass index (BMI), apnea/
hypopnea index (AHI) and maximum O
2
 saturation - the 
last two based on polysomnography (Stellat System QC, 
Harmonie TM, Canada) recordings. Patients were allocated 
to the following age groups: young adults (18 to 40 years), 
adults (41 to 65 years), and elderly (> 65 years).18,19 The 
classification based on the apnea/hypopnea (AHI) was: 
mild OSAHS (AHI from 5 to 15 events/hour), moderate 
OSAHS (AHI from 16 to 30 events/hour), severe OSAHS 
(AHI > 30 events/hour).20,21 The classification of patients 
based on the BMI (World Health Organization) was: ideal 
weight (18.5-24.9 Kg/m2), overweight (25.0-29.9 Kg/m2), 
and grade I obesity (30.0-34.9 Kg/m2).22 A BMI ≤ 30 limit 
was established so that higher obesity grades would not 
bias serum testosterone levels.
A peripheral venous blood sample was taken in 
a dry tube to measure quantitative total testosterone by 
the competitive immunoassay method (direct chemilumi-
nescent technology) using an ADVIA Centaur (Siemens 
Medical Solutions Diagnostics, NY, USA) commercial 
system. Peripheral venous blood was also sampled and 
placed in a tube containing EDTA anticoagulant for the 
red blood count. The Ht and Hb levels were measured 
with an automatic cell counter (Horiba ABX Diagnostics, 
Pentra DF 120, Montpellier, France). Reference values for 
total testosterone (245-1836 ng/dl), the Ht (40.7-50.3%), 
and Hb (14.5-18.0 g/dl) in men are aligned with the pro-
tocols of the cell counting and hormone dosage systems 
of the Central Laboratory of our institution.
The institutional review board approved this study 
(Document no. 365/2009).
 
Statistics
The results were analyzed statistically for normalcy. 
The two-tailed Student’s t test was applied for normally 
distributed independent samples, and the Mann-Whitney 
test was applied for non-normally distributed samples. The 
chi-square test was applied when appropriate for compa-
risons among variables. The significance level was 5%.
RESULTS
Of 103 OSAHS patients, 79 (77%) had testosterone 
levels within normal limits, and 24 (23%) had testosterone 
levels below reference values.
Adults comprised 57 patients (72%) with normal 
testosterone levels and 18 patients (75%) with altered 
testosterone levels. No patient aged over 65 years had 
altered testosterone levels.
The BMI showed that 70% of OSAHS patients with 
normal testosterone levels were overweight, while 63% of 
OSAHS patients with altered testosterone levels had grade 
I obesity; this relation was statistically significant (p<0.05).
The AHI revealed that the severe grade was more 
prevalent in both OSAHS patients with normal (52%) and 
altered (50%) testosterone levels. Similarly, maximum O
2
 
saturation over 90% was prevalent in both OSAHS patients 
with normal (84%) and altered testosterone levels (79%).
Table 1 shows the general data for the sample.
Table 2 shows that OSAHS patients with altered 
testosterone levels had significant lower mean Ht, Hb and 
serum testosterone levels compared to OSAHS patients 
with normal testosterone levels. The mean BMC of OSAHS 
patients with altered testosterone levels was significantly 
higher compared to the mean BMC of OSAHS patients 
with normal testosterone levels.
DISCUSSION
There has been a growing awareness that sex hor-
mones play an important role in nearly every physiological 
process, including breathing. Estrogen, progesterone, and 
testosterone may affect respiratory function in animals and 
humans.9,23 The prevalence of several respiratory disorders, 
such as OSAHS, the sudden death syndrome in infants, and 
Rett’s syndrome, varies according to gender, which under-
lines the effect of sex hormones on breathing control.24-26
Long-term respiratory facilitation is an interesting 
model, making it possible to study the effects of sex 
hormones on neuroplasticity in general, and specifically 
on respiratory plasticity. Because of upper airway muscle 
rigidity, long-term facilitation allows breathing to become 
91
Brazilian Journal of otorhinolaryngology 77 (1) January/feBruary 2011
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
stable under conditions that otherwise might result in 
upper airway obstruction and apnea. Although the role 
of long-term facilitation has not been clearly defined as 
a causal factor of OSAHS, changes that affect respiratory 
plasticity - such as decreased sex hormone levels with 
aging - may foster the progression of this syndrome.1
The incidence of OSAHS is higher in men with lo-
wer serum testosterone levels, in middle-aged men,27,28 in 
women with low estrogen and progesterone levels, and 
in post-menopausal women not on hormone replacement 
therapy.11,29,30 The present study found low serum levels of 
total testosterone in OSAHS patients, most of which had 
Table 1. Distribution as percentages (%) of the serum testosterone results found in OSAHS patients (n=103)
Variables
Normal testosterone 
79 (77%)
Low testosterone 
24 (23%)
p*
BMI    
Overweight 55 (70%) 9 (37%)
<0,05
Grade I obesity 24 (30%) 15 (63%)
Age group (Classification)    
Young adult 21 (27%) 6 (25%)
 >0,05Adult 57 (72%) 18 (75%)
Elderly 41 (52%) 0 (0%)
Polysomnography (PSG) data
AHI    
Mild 28 (35%) 5 (21%)
 >0,05Moderate 10 (13%) 7 (29%)
Severe 41 (52%) 12 (50%)
Maximum O2 Saturation    
> 90% 66 (84%) 19 (79%)
>0,05
< 90% 13 (16%) 15 (63%)
AHI - apnea/hypopnea index.
BMI - body mass index.
Normal testosterone - serum levels from 245 to 1836 ng/dl.
Low testosterone - serum levels below 245 ng/dl.
* Chi-square test.
Table 2. Clinical and anthropometric features of OSAHS patients (n=103) and serum testosterone levels
Parameters Normal Testosterone (n=79) Low Testosterone (n=24) p
Testosterone (ng/dl) 404,0 ± 132,6 200,4 ± 26,7 p≤0,001*
AHI (grade) 34,4 ± 24,4 36,1 ± 22,0 NS
Maximum O2 saturation (%) 91,6 ± 3,8 92,1 ± 4,3 NS
BMI (grade) 27,7 ± 2,3 29,4 ± 1,0 p≤0,01*
Age group (years) 46,1 ± 10,1 44,6 ± 9,8 NS
Hematocrit (%) 46,1 ± 3,5 44,4 ± 3,0 p≤0,05”
Hemoglobin (g/dl) 15,2 ± 1,1 14,6 ± 1,0 p≤0,05”
Values are presented as means ± standard deviation.
AHI - apnea/hypopnea index.
BMI - body mass index.
Normal testosterone - serum levels from 245 to 1836 ng/dl.
Altered testosterone - serum levels lower than 245 ng/dl.
* Mann-Whitney test.
“Two-tailed Student’s t test for independent variables.
NS - Not significant
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a mean age of 44.6 years, grade I, and mild AHI; these 
results concur with other published studies.17,27,31-34
Several factors may account for lower testosterone 
secretion levels in middle-aged men with OSAHS; these 
include: hypoxia, fragmented sleep, obesity, and advanced 
age. Previous studies on hypophysary-gonadal function in 
OSAHS have demonstrated that serum testosterone levels 
may be lower. Total and free testosterone levels were lower 
in obese males with OSAHS compared to age and body 
weight paired control group. A negative correlation was 
found between the severity of sleep apnea and testosterone 
levels; higher AHIs correlate with lower testosterone levels, 
suggesting that the severity of apnea was related with de-
creased testosterone secretion in OSAHS.31,33 This concept, 
however, remains controversial; lower testosterone levels 
have been found not only in patients with mild OSAHS 
but also in elderly obese patients with a severe AHI.35
Serum testosterone levels decrease with age. Hy-
pogonadal testosterone levels have been found in about 
12% of men aged over 50 years, and in 50% of men aged 
over 80 years.27,36 Central (hypophysary) and peripheral 
(testicular) effects cause age-related reduction in testoste-
rone levels.27,37 In the present study, sub-normal hormone 
levels were found in 50% of severe OSAHS patients grave 
with grade I obesity (63%); however, most of these patients 
were in the adult age group (75%) rather than elderly sub-
jects. Among patients with normal testosterone levels, the 
majority (52%) had severe AHI, and 72% were adults. The 
BMI placed these patients in the overweight group (70%).
Although published papers have reported an asso-
ciation between lower testosterone levels and higher than 
grade I BMIs27,31 our results in the present study showed 
that patients with lower testosterone levels and grade I 
BMI presented this association at a higher rate compared 
to patients with normal testosterone levels. This finding 
suggests that in patients with altered hormone levels, grade 
I BMI correlated with lower testosterone levels. Obesity is 
common in patients with OSAHS, and is associated with 
increased severity of sleep apnea, as shown by the AHI.38
Possible mechanisms to explain the association 
between OSAHS and obesity include several endocrine 
abnormalities involved in fat accumulation - especially ab-
dominal fat - where lower androgen levels appear to have 
a significant role. Androgens stimulate fat lipolysis and 
inhibit the lipase lipoprotein, especially in the abdomen. 
Testosterone regulation of fat metabolism may explain 
why hypogonadal men invariably present increased levels 
of abdominal fat. Total and free testosterone levels fall in 
obese males - as body weight and fat increase - because of 
decreased globulin-bound hormone synthesis and altered 
activity of the aromatase system in peripheral tissues.39-41
Prior studies have shown that serum levels of testos-
terone are inversely correlated with the severity of OSAHS 
(AHIs); such altered levels result from fragmented sleep 
and decreased oxygenation, which are known inhibitors 
of testosterone production.27,33 A cross-sectional study of 
225 male subjects undergoing polysomnography showed 
that the severity of OSAHS correlated significantly with 
globulin-bound sex hormones, decreased levels of total 
testosterone, and free testosterone.42 Our data did not 
confirm these results, as although 50% of OSAHS patients 
with low testosterone levels had severe apnea, a similar 
prevalence (52%) was found in OSAHS patients with 
normal testosterone levels. Further studies are needed to 
clarify which factors cause apnea index severity in the 
study population.
Oxygen desaturation affects testosterone levels by 
mechanisms that remain unclear. Decreased O
2
 availability 
during sleep has been associated with central inhibition 
of the hypothalamic-hypophyseal-gonadal axis, probably 
by increasing central endorphin levels. Furthermore, 
when patients are repeatedly exposed to upper airway 
obstruction episodes with clear sleep fragmentation, the 
circadian rhythm of testosterone appears to be affected.43 
Prior studies have described the relative importance of 
hypoxia and fragmented sleep on the genesis of gonadal 
dysfunction; these studies have shown that sleep depri-
vation was associated with gonadal steroid suppression 
in normal young adults.43,44 Comparing OSAHS patients 
presenting severe O
2
 desaturation with OSAHS patients 
presenting less severe O
2
 desaturation revealed a significant 
correlation between peak testosterone levels and the total 
O
2
 desaturation time. This finding suggests that hypoxia 
affected the circadian rhythm of testosterone, resulting in 
decreased morning levels of this hormone.43,45
OSAHS patients presenting chronic hypoxemia may 
have ventilatory issues, as hypoxemia affects the synthesis 
and activity of several neurotransmitters, thereby changing 
the function of central and peripheral chemoreceptors 
that control ventilation.46 Prior studies have demonstrated 
the effect of the AHI on testosterone secretion, and have 
emphasized the degree of hypoxia. It is possible that hypo-
xia and fragmented sleep affect the hypophysary-gonadal 
function in OSAHS patients. A low testosterone level and 
its significant association with the AHI suggest that gona-
dal dysfunction is a consequence of OSAHS, rather than 
an independent primary condition of the hypothalamic-
hypophyseal-gonadal axis.27,43,45
Although the relation between patient groups 
and mean AHI values and mean PaO2 values was not 
significant in the present study, 63% of patients with low 
testosterone levels had a PaO
2 
< 90% compared to 16% 
of patients with normal testosterone levels. And although 
the mean Ht and Hb values were within normal limits, 
there was a statistically significant difference between both 
groups of OSAHS patients, indicating a relative decrease 
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in these values in patients with lower testosterone levels.
Endogenous androgens in mammals stimulate 
erythropoiesis, raise the reticulocyte count and the number 
of blood cells, and promote erythropoietic activity in the 
bone marrow; castration has the opposite effect. Testoste-
rone deficiency causes a 10% to 20% reduction in the Hb 
concentration, which may result in anemia. Young male 
subjects with hypogonadism generally have low red blood 
cell counts and lower levels of Hb compared to similarly 
aged males with normal androgen levels. Androgens affect 
normal hematopoiesis by directly stimulating - through tes-
tosterone - renal production of erythropoietin.47 Androgen 
deprivation in men reduces erythropoiesis; hypogonadism 
is frequently associated with decreased Ht levels, as in our 
sample, which however were still within normal referen-
ce limits. Age-related anemia is at least partially due to 
declining levels of circulating androgens in older men.48,49
OSAHS patients may have decreased testosterone 
levels probably because of a combined effect of frag-
mented sleep and hypoxia. As sleep begins, the plasma 
testosterone concentration is low because maximal levels 
are reached during the first hours of the morning. Higher 
testosterone levels at night appear to be associated with 
the first episode of REM sleep and REM/non-REM cycles. 
Peak testosterone levels coincide with the onset of REM 
sleep. Furthermore, sleep-related elevation of testosterone 
levels in young men is associated with the first episode of 
REM sleep at night. A study of fragmented sleep in young 
males showed that the nocturnal peak concentration of 
testosterone was lower in men that did not enter REM 
sleep.45,50 Thus, we chose to measure testosterone levels 
in the morning after polysomnography was done, thereby 
identifying nighttime increases or not of testosterone in 
patients.
Low serum testosterone levels have been noted 
in obese, diabetic, hyperlipidemic, and insulin-resistant 
patients, as well as those with the metabolic syndrome. 
Serum testosterone levels in men deserve additional studies 
because of advances in knowledge about the cardiovas-
cular aspects of hypogonadism and about OSAHS with 
or without associated metabolic conditions. It is not yet 
clear if OSAHS results in decreased testosterone levels by 
itself, or if obese, insulin-resistant and/or diabetic older 
OSAHS patients are at a higher risk of having lower levels 
of testosterone.17
Our findings in the present study and other publi-
shed results may have practical implications for the treat-
ment of obese OSAHS patients. Nutritional and behavioral 
therapy for rapid weight loss and long-term maintenance 
of weight has an important role for improving respiratory 
function and reducing metabolic disorders. Furthermore, 
testosterone levels tend to increase significantly after 
weight loss, which may help keep weight within normal 
limits.51
Endocrine abnormalities in OSAHS may be rever-
ted following three months of continuous positive airway 
pressure (CPAP) therapy.28,32 However, normal testosterone 
levels have also been found in OSAHS patients using CPAP 
or not,52 as encountered the present study. Differences 
in these results may be due to the degree of OSAHS, to 
globulin-bound sex hormone levels, or to intermittent du-
ration of CPAP and other similar therapies; these situations 
may explain unaltered testosterone levels.
The data suggest that OSAHS in middle-aged men is 
associated with decrease androgen secretion, together with 
obesity and aging. Hypoxia and fragmented sleep may be 
additional factors that decrease testosterone levels in these 
patients,33 as we found in the present study. Testosterone 
has been an object of research and reviews in several stu-
dies of male subjects; few of these papers have touched 
on the interaction between testosterone levels and sleep. 
Additional knowledge about this relationship is important 
for understanding the basic physiology of sleep and to 
help discover the causes of specific health issues associa-
ted with sleep disorders, aging, and even working hours. 
Knowledge about the interactions between hormones and 
breathing opens new perspectives in drug therapies for 
sleep disorders; it also stimulates research about how the 
endocrine system affects breathing in health and disease.53
CONCLUSION
OSAHS may be associated with decreased hypo-
physary-gonadal function in the study sample.
A relation between serum levels of testosterone in 
the morning and obesity may account for central testos-
terone suppression in the study sample.
No conclusion could be drawn from the study re-
sults about any relation between altered serum testosterone 
levels and age, the AHI, or hypoxia.
Decreased red blood cell hematimetric values in 
the study sample may be related with low circulating 
testosterone levels.
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